You are here
Planning Framework
The NBA has an established comprehensive planning framework as depicted in Figure 3.3.
Current programs include:
- National Supply and Funding
- National Risk Assessment and Management
- Immunoglobulin Governance
- National Guidelines Development and Implementation
- National Supply Efficiency and Wastage Reduction
- Information Management and Technology
- Blood Sector Knowledge Development
- Research and Development
- Corporate Governance and Management.
FIGURE 3.3 NBA Planning Framework
Progress against the Business Plan is monitored and reviewed by the NBA Business Committee quarterly. A quarterly report on progress against key actions is also provided to the NBA Board and Audit Committee.
In 2017-18, the NBA delivered 70 per cent of activities against the planned outcomes. Table 3.1 demonstrates the overall trend in the NBA's delivery against the business plan over the past five years. Some activities have been delayed due to revision of timelines and changing priorities as agreed by the Executive.
TABLE 3.1 NBA's performance in achieving business plan objectives, 2013-14 to 2017-18.
|
Year
|
2013-14
|
2014–15
|
2015–16
|
2016-17
|
2017-18
|
|---|---|---|---|---|---|
|
Performance (%) |
96% |
91% |
97% |
98% |
70% |
Key operational achievements for 2017-18 included the following:
- the uninterrupted supply of blood and blood products to meet all clinical demand in accordance with the approved National Supply Plan and Budget (NSP&B)
- the National Supply Plan and Budget (NSP&B) approved by COAG Health Council in accordance with Schedule 3 of the National Blood Agreement
- continued to implement the Deed of Agreement with the Australian Red Cross Blood Service
- negotiated and implemented a new nine year contract with CSL Behring Australia Pty Ltd for the manufacture and supply of fractionated blood plasma products commenced in January 2018
- worked with jurisdictions to develop the revised National Wastage Reduction Strategy, now known as the National Blood Product Management Improvement Strategy 2018-22
- commenced the development of a revised National IT and Data Strategy for 2018-2022
- continued the review and revision of the Criteria for access to immunoglobulin products under the national blood arrangements
- continued the national blood sector research and development funding program and sought applications for Round 3 grants
- continued collaborative work with the Australian Commission on Safety and Quality in Health Care (ACSQHC) on the development of resources for the second edition of the National Safety and Quality Health Service (NSQHS) Standards, Standard 7- Blood Management
- Workplace Health and Safety Governance Framework implemented.
National Blood Authority Service Charter Ongoing quality improvement process
The NBA developed a new and simplified service charter in 2017-18.
The revised NBA service charter forms an integral part of our business improvement process and enhances the way we conduct our day-to-day business. In essence, our service charter outlines:
- our ongoing commitment to the high standard of service that our stakeholders have come to expect from us
- the expectations that we have of our stakeholders so that they can help us deliver the highest standards of service.
The NBA service charter is available on the NBA website at www.blood.gov.au/charter.
Further complementing our business process is our streamlined feedback mechanism. We are committed to providing a high level of service to all our stakeholders and we welcome feedback on our level of service on an ongoing basis. Stakeholders can provide feedback directly to us via our website on www.blood.gov.au/feedback. Feedback is recorded, monitored and acted upon as appropriate, with a view to improving our performance and, ultimately, our level of service.
The NBA did not receive any formal negative feedback in 2017-18.
